青松股份(300132) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥397,071,868.20, a decrease of 42.22% compared to ¥687,223,216.02 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥47,920,164.17, an improvement of 21.69% from a loss of ¥61,195,748.76 in the previous year[4] - The net cash flow from operating activities decreased by 69.60% to ¥29,554,424.41 from ¥97,211,444.26 year-on-year[4] - Operating revenue for the first quarter of 2023 was CNY 397,071,868.20, down 42.3% from CNY 687,223,216.02 in the same period last year[33] - The net profit for Q1 2023 was -47,765,385.92 CNY, an improvement from -60,955,836.68 CNY in Q1 2022, representing a decrease in net loss of approximately 21.5%[34] - Operating profit for Q1 2023 was -55,279,133.95 CNY, compared to -63,532,710.53 CNY in the same period last year, indicating a reduction in operating loss of about 13.5%[34] - The total comprehensive income for Q1 2023 was -48,602,216.97 CNY, compared to -61,181,455.24 CNY in Q1 2022, indicating a reduction in comprehensive loss of about 20.5%[35] Cash Flow and Investments - The net cash flow from investing activities increased by 211.28% to ¥221,754,738.85, primarily due to the recovery of receivables from the subsidiary Qing Song Chemical[17] - The net cash flow from financing activities decreased by 249.48% to -¥173,846,438.86, mainly due to the repayment of bank loans[17] - The net increase in cash and cash equivalents decreased by 73.39% to ¥75,680,156.23 from ¥284,400,704.16 in the previous year[17] - Cash flow from operating activities showed a net inflow of 29,554,424.41 CNY, significantly lower than 97,211,444.26 CNY in the previous year, marking a decrease of about 69.6%[38] - Investment activities generated a net cash inflow of 221,754,738.85 CNY, a substantial increase from 71,238,728.76 CNY in Q1 2022, representing a growth of approximately 211.5%[38] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥2,817,454,183.29, down 11.81% from ¥3,194,595,271.44 at the end of the previous year[6] - The company's total liabilities decreased from CNY 1,813,207,019.28 to CNY 1,484,668,148.10 during the same period[31] - The company's non-current liabilities decreased from CNY 617,584,484.07 to CNY 561,225,516.22, a decline of 9.1%[31] - The retained earnings showed a negative balance of CNY -474,082,578.69, worsening from CNY -426,162,414.52 at the beginning of the year[31] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,036, with no preferred shareholders[18] - The top shareholder, North Bell (Hong Kong) Non-woven Fabric Co., Ltd., holds 9.17% of shares, totaling 47,392,045 shares[18] Research and Development - Research and development expenses decreased by 37.47% to ¥16,606,592.64 from ¥26,556,845.90 year-on-year[14] Financial Expenses - The company reported a significant reduction in financial expenses by 66.94% to ¥5,068,004.19 from ¥15,330,453.81 due to a substantial decrease in loan balances[14] Subsidiary Performance - The subsidiary North Bell Cosmetics achieved revenue of ¥394,657,200, a year-on-year decline of 9.65%, with a net profit attributable to shareholders of -¥44,264,700, a year-on-year increase of 9.61%[22] - The company has focused its resources on the cosmetics and consumer goods sectors, completing the sale of two wholly-owned subsidiaries for a total of ¥284,224,700[23] - The company has fully recovered the inter-company loans and interest from Qing Song Chemical, amounting to ¥421,832,663.88[23] Deferred Income - The deferred income increased by 40.45% to ¥30,485,745.40, reflecting an increase in government subsidies received[12] Inventory and Receivables - Accounts receivable decreased significantly from CNY 522,388,082.36 to CNY 392,430,108.62, a decline of 25%[28] - Inventory levels decreased from CNY 421,740,785.65 to CNY 366,970,108.17, a reduction of 12.99%[28]